167 related articles for article (PubMed ID: 35033661)
1. PTEN: A novel target for vitamin D in melanoma.
Shariev A; Painter N; Reeve VE; Haass NK; Rybchyn MS; Ince FA; Mason RS; Dixon KM
J Steroid Biochem Mol Biol; 2022 Apr; 218():106059. PubMed ID: 35033661
[TBL] [Abstract][Full Text] [Related]
2. Role of vitamin D3 in modulation of ΔNp63α expression during UVB induced tumor formation in SKH-1 mice.
Hill NT; Gracia-Maldonado GH; Leonard MK; Harper AR; Tober KL; Oberyszyn TM; Kadakia MP
PLoS One; 2014; 9(9):e107052. PubMed ID: 25191969
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D and systemic cancer: is this relevant to malignant melanoma?
Osborne JE; Hutchinson PE
Br J Dermatol; 2002 Aug; 147(2):197-213. PubMed ID: 12174089
[TBL] [Abstract][Full Text] [Related]
4. Ultraviolet damage, DNA repair and vitamin D in nonmelanoma skin cancer and in malignant melanoma: an update.
Reichrath J; Rass K
Adv Exp Med Biol; 2014; 810():208-33. PubMed ID: 25207368
[TBL] [Abstract][Full Text] [Related]
5. The vitamin D receptor: a tumor suppressor in skin.
Bikle DD
Adv Exp Med Biol; 2014; 810():282-302. PubMed ID: 25207372
[TBL] [Abstract][Full Text] [Related]
6. On the role of classical and novel forms of vitamin D in melanoma progression and management.
Slominski AT; Brożyna AA; Skobowiat C; Zmijewski MA; Kim TK; Janjetovic Z; Oak AS; Jozwicki W; Jetten AM; Mason RS; Elmets C; Li W; Hoffman RM; Tuckey RC
J Steroid Biochem Mol Biol; 2018 Mar; 177():159-170. PubMed ID: 28676457
[TBL] [Abstract][Full Text] [Related]
7. Anti-proliferative action of vitamin D in MCF7 is still active after siRNA-VDR knock-down.
Costa JL; Eijk PP; van de Wiel MA; ten Berge D; Schmitt F; Narvaez CJ; Welsh J; Ylstra B
BMC Genomics; 2009 Oct; 10():499. PubMed ID: 19863778
[TBL] [Abstract][Full Text] [Related]
8. In vitro comparison of the vitamin D endocrine system in 1,25(OH)2D3-responsive and -resistant melanoma cells.
Reichrath J; Rech M; Moeini M; Meese E; Tilgen W; Seifert M
Cancer Biol Ther; 2007 Jan; 6(1):48-55. PubMed ID: 17172823
[TBL] [Abstract][Full Text] [Related]
9. The Role of Classical and Novel Forms of Vitamin D in the Pathogenesis and Progression of Nonmelanoma Skin Cancers.
Slominski AT; Brożyna AA; Zmijewski MA; Janjetovic Z; Kim TK; Slominski RM; Tuckey RC; Mason RS; Jetten AM; Guroji P; Reichrath J; Elmets C; Athar M
Adv Exp Med Biol; 2020; 1268():257-283. PubMed ID: 32918223
[TBL] [Abstract][Full Text] [Related]
10. CYP11A1 in skin: an alternative route to photoprotection by vitamin D compounds.
Tongkao-On W; Carter S; Reeve VE; Dixon KM; Gordon-Thomson C; Halliday GM; Tuckey RC; Mason RS
J Steroid Biochem Mol Biol; 2015 Apr; 148():72-8. PubMed ID: 25448743
[TBL] [Abstract][Full Text] [Related]
11. VDR microRNA expression and epigenetic silencing of vitamin D signaling in melanoma cells.
Essa S; Denzer N; Mahlknecht U; Klein R; Collnot EM; Tilgen W; Reichrath J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):110-3. PubMed ID: 20153427
[TBL] [Abstract][Full Text] [Related]
12. Endocrine actions of vitamin D in skin: Relevance for photocarcinogenesis of non-melanoma skin cancer, and beyond.
Reichrath J; Saternus R; Vogt T
Mol Cell Endocrinol; 2017 Sep; 453():96-102. PubMed ID: 28526240
[TBL] [Abstract][Full Text] [Related]
13. Protective actions of vitamin D in UVB induced skin cancer.
Bikle DD
Photochem Photobiol Sci; 2012 Dec; 11(12):1808-16. PubMed ID: 22990497
[TBL] [Abstract][Full Text] [Related]
14. Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice.
Zinser GM; McEleney K; Welsh J
Mol Cell Endocrinol; 2003 Feb; 200(1-2):67-80. PubMed ID: 12644300
[TBL] [Abstract][Full Text] [Related]
15. Signature of VDR miRNAs and epigenetic modulation of vitamin D signaling in melanoma cell lines.
Essa S; Reichrath S; Mahlknecht U; Montenarh M; Vogt T; Reichrath J
Anticancer Res; 2012 Jan; 32(1):383-9. PubMed ID: 22213330
[TBL] [Abstract][Full Text] [Related]
16. IL-6 Impairs the Activity of Vitamin D3 in the Regulation of Epithelial-Mesenchymal Transition in Triple Negative Breast Cancer.
Abdel-Mohsen MA; Abo Deif SM; Abou-Shamaa LA
Asian Pac J Cancer Prev; 2019 Aug; 20(8):2267-2273. PubMed ID: 31450894
[TBL] [Abstract][Full Text] [Related]
17. PTEN: new insights into its regulation and function in skin cancer.
Ming M; He YY
J Invest Dermatol; 2009 Sep; 129(9):2109-12. PubMed ID: 19340009
[TBL] [Abstract][Full Text] [Related]
18. The Tumor Suppressor FBW7 and the Vitamin D Receptor Are Mutual Cofactors in Protein Turnover and Transcriptional Regulation.
Salehi-Tabar R; Memari B; Wong H; Dimitrov V; Rochel N; White JH
Mol Cancer Res; 2019 Mar; 17(3):709-719. PubMed ID: 30606768
[TBL] [Abstract][Full Text] [Related]
19. UVB-induced ERK/AKT-dependent PTEN suppression promotes survival of epidermal keratinocytes.
Ming M; Han W; Maddox J; Soltani K; Shea CR; Freeman DM; He YY
Oncogene; 2010 Jan; 29(4):492-502. PubMed ID: 19881543
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D and skin cancer.
Burns EM; Elmets CA; Yusuf N
Photochem Photobiol; 2015; 91(1):201-9. PubMed ID: 25378147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
